Racial/Ethnic Differences in Trust/Mistrust and Its Effect on Diabetes Outcomes
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00383110|
Recruitment Status : Completed
First Posted : October 2, 2006
Results First Posted : September 17, 2014
Last Update Posted : April 28, 2015
- Determine racial/ethnic differences in trust in physicians and mistrust of the health care system among veterans with Type 2 Diabetes.
- Determine the predictive power of trust in physicians and mistrust of the health care system on personal health practices and health outcomes in a prospective cohort of veterans with Type 2 Diabetes
|Condition or disease|
Show Detailed Description
|Study Type :||Observational|
|Actual Enrollment :||300 participants|
|Official Title:||Racial/Ethnic Differences in Trust/Mistrust and Its Effect on Diabetes Outcomes|
|Study Start Date :||November 2004|
|Actual Primary Completion Date :||January 2009|
|Actual Study Completion Date :||January 2009|
Adults (age 18 or older) with type 2 diabetes.
- General Trust in Physicians Scale (GTIPS) [ Time Frame: 12 months following enrollment ]The GTIPS is a valid and reliable 11-item measure of general trust in physicians in the domains of dependability, confidence, and confidentiality of information. All items are fashioned in a 5-point Likert format with a minimum score of 11 and maximum of 55. Higher scores indicate more trust in physicians.
- Health Care System Distrust Scale [ Time Frame: 12 months after enrollment ]Health Care System Distrust Scale is a valid and reliable 10-item measure of distrust of the health care system, measuring honesty confidentiality and confidence. All questions are measured on a Likert scale, with scores ranging from a minimum of 10 to a maximum of 50. Higher scores indicate more distrust in the health care system.
- Hemoglobin A1c [ Time Frame: 12 months after enrollment ]
- Systolic Blood Pressure [ Time Frame: 12-months after enrollment ]
- Diastolic Blood Pressure [ Time Frame: 12-months after enrollment ]
- LDL-cholesterol [ Time Frame: 12-months after enrollment ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00383110
|United States, South Carolina|
|Ralph H. Johnson VA Medical Center, Charleston, SC|
|Charleston, South Carolina, United States, 29401-5799|
|Principal Investigator:||Leonard E. Egede, MD MS||Ralph H. Johnson VA Medical Center, Charleston, SC|